Ideas to Action:

Independent research for global prosperity

Publications

 

October 22, 2020

Testimony before the USITC on COVID-19 Related Medical Supply Chains

On Wednesday, September 23, CGD Senior Fellow Prashant Yadav appeared before the United States International Trade Commission (USITC) at a virtual hearing examining “COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges.” His testimony focused on trade and supply chain issues for COVID-19 related medical products and he offered recommendations for building more resilient supply chains.

A cover image of a COVID-19 vaccine prediction paper
October 1, 2020

COVID-19 Vaccine Predictions: Using Mathematical Modelling and Expert Opinions to Estimate Timelines and Probabilities of Success of COVID-19 Vaccines

We collected publicly available information, interviewed experts, and used our diverse range of expertise to analyse and model the COVID-19 vaccine portfolio in order to generate predictions about the vaccine portfolio's timeline.

July 24, 2020

Testimony on Critical US Supply Chains Amid the COVID-19 Pandemic

On July 23, 2020, CGD Senior Fellow Prashant Yadav appeared before the House Ways and Means Subcommittee on Trade at a hearing titled “Trade, Manufacturing, and Critical Supply Chains: Lessons From COVID-19.” Yadav’s testimony noted the vulnerabilities in supply chains for medical products clearly exposed by the COVID-19 pandemic and outlined key considerations for US policy toward medical supply chains moving forward.

An image of a Covid-19 vaccine
June 4, 2020

India’s COVID-19 Testing Capacity Must Grow by a Factor of 10: Here’s How That Can Happen

Diagnostic testing is at the center of the policy debate around COVID-19 interventions in India. As of June 1, 2020, India had conducted approximately 3.8 million tests since it began testing in February, but many experts have noted that testing capacity is still drastically insufficient for the needs of the population.

Prashant Yadav , Abha Mehndiratta , Kalipso Chalkidou , Sidharth Rupani and Krishna Reddy
May 5, 2020

COVID-19 and Oxygen: Selecting Supply Options in LMICs that Balance Immediate Needs with Long-Term Cost-Effectiveness

Much of the policy debate regarding COVID-19 medical equipment focuses on the question of which form of patient respiratory support is effective in low-resources settings. However, irrespective of the specific form of respiratory support used, the long-term and cost-effective functioning of all forms of oxygen therapy requires an appropriate system to supply oxygen to hospitals.

Lisa Smith , Tim Baker , Gabriel Demombynes and Prashant Yadav
Vaccine manufacturing plant. Adobe Stock
April 25, 2020

Delivering on the Promise of “Equitable Access” to Epidemic Vaccines and Treatments: the Need for Norms, Processes, and Evidence to Guide Supply and Allocation

While there has been much interest and investment in developing epidemic vaccines and medicines to combat emerging infectious disease threats, there has been less attention to how we will manage and allocate the global supply of efficacious vaccines and treatments once we have them. The launch of the Access to COVID-19 Tools (ACT) Accelerator marks an unprecedented commitment to global collaboration to ensure rapid and equitable access to medical countermeasures for COVID-19, such as vaccines and treatments.